Aurbindo Pharma warned by USFDA
Mumbai, Jan 14 :Pharmaceuticals company Aurobindo Pharma Today said it has received a 'warning letter' from the USFDA for one of its API (active pharmaceutical ingredient) manufacturing facility in Hyderabad.This action follows the recent inspection…